HCPLive

Daxdilimab Depletes pDCs in Discoid Lupus, With Victoria Werth, MD

Oct 9, 2026 · 0:04:37

Listen to Episode

✨ AI Summary

Daxdilimab depletes plasmacytoid dendritic cells in discoid lupus.
Phase 2 results for treatment-refractory discoid lupus presented at EADV.
Anti-ILT7 antibody targets type I interferon activity in cutaneous lupus.

Guests on This Episode

researcher (dermatology) · 1 podcast appearance

More from HCPLive

Subcutaneous Furosemide Bioequivalent to IV, Bioavailable Across Multiple Injection Sites

Oct 12, 2026 · 0:03:18

Targeting Senescent Cells in Actinic Keratosis With RLS-1496

Oct 12, 2026 · 0:04:25

Atopic Dermatitis Biologic Selection, With Raj Chovatiya, MD, PhD

Oct 12, 2026 · 0:03:33

Tovinontrine 50 mg Improves cGMP With Minimal Effect on NT-proBNP in HFpEF

Oct 12, 2026 · 0:06:00

View all episodes →